Skip to main content
Back to Current Affairs
Science & TechnologySource: The Hindu

Innovative Treatment Approaches for Drug-Resistant Pneumonia using Nitric Oxide

Monday, 16 February 2026
Read Original Article

Key Points

Innovative Treatment Approaches for drug-resistant pneumonia have emerged, particularly using high-dose inhaled nitric oxide (300 ppm). This treatment significantly reduces the incidence of drug-resistant pneumonia, especially caused by Pseudomonas aeruginosa, a major concern in ICUs. The study underscores the importance of finding new strategies to tackle antimicrobial resistance.

Detailed Coverage

  • High-dose inhaled nitric oxide (300 ppm) shows promise against drug-resistant pneumonia.
  • Drug-resistant pneumonia is a severe issue in Intensive Care Units (ICUs).
  • Responsible for approximately one in five hospital pneumonias.
  • Condition caused by bacteria resistant to antibiotics.
  • Key pathogens include Streptococcus pneumoniae and MRSA.
  • Gram-negative bacteria like Pseudomonas aeruginosa are prevalent in hospital-acquired pneumonia.
  • Delayed response can lead to severe outcomes, including sepsis or death.
  • Nitric oxide is a colorless gas with a short half-life.
  • Produced from L-arginine by nitric oxide synthases (NOS).
  • Functions as a vasodilator in the cardiovascular system.
  • Acts as a neurotransmitter in the nervous system.
  • Exhibits antimicrobial properties, disrupting pathogen metabolism.
  • Discovery of nitric oxide led to the 1998 Nobel Prize in Physiology.
  • The study emphasizes innovative approaches to combat antimicrobial resistance.
  • Highlights the need for new treatment strategies.
  • Potential game-changer in managing drug-resistant infections.
Science & Technology

Practice Questions

Test your understanding of this article

Question 1 of 50 / 5 answered
1

The discovery of nitric oxide (NO) as a critical physiological agent led to significant advancements in medical science, culminating in a prestigious award. In which year was the Nobel Prize in Physiology awarded for the elucidation of NO's role as the endothelium-derived relaxing factor (EDRF)?